Although there are no regulatory requirements or established pharmacopoeial techniques for the dissolution testing of inhaled drugs, such testing can potentially open up the opportunity to tailor ...

Early adoption of the right approach to address solubility can deliver significant benefits. Currently, a significant proportion of drugs that are approved or in the development pipeline are poorly ...

Announcing a new article publication for BIO Integration journal. Nitrofurantoin is a BCS II drug with a low solubility and dissolution rate. Therefore, the pharmaceutical applications of ...